HELX ETF
Franklin Genomic Advancements ETF
GH is HELX's largest holding at 9.29% of the fund as of Sep 15, 2026. HELX is Franklin Genomic Advancements ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | G | Guardant Health, IncHealth Care · Biotechnology | 9.29% | 9.3% | 18,136 | $2.85M | Health Care | Biotechnology |
| 2 | N | Natera IncHealth Care · Biotechnology | 8.81% | 18.1% | 8,227 | $2.71M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | K | Krystal Biotech Inc | 5.75% | 23.9% | 5,096 | $1.77M | ||
| 4 | L | Ligand Pharmaceuticals, Inc. | 4.41% | 28.3% | 4,768 | $1.36M | ||
| 5 | A | Adaptive Biotechnologies Corp | 4.38% | 32.6% | 55,667 | $1.35M | ||
| 6 | T | Twist Bioscience Corp. | 3.75% | 36.4% | 9,069 | $1.15M | ||
| 7 | B | Bridgebio Pharma Inc_None_0 | 3.32% | 39.7% | 14,066 | $1.02M | ||
| 8 | T | Travere Therapeutics Inc | 3.26% | 43.0% | 15,153 | $1.00M | ||
| 9 | — | Nvaesrtex Pharmaceuticals Inc | 2.78% | 45.8% | 1,655 | $853.1K | ||
| 10 | M | Medpace Holdings Inc | 2.71% | 48.5% | 1,415 | $831.3K | ||
| 11 | C | Corteva Inc Ctva | 2.68% | 51.1% | 9,800 | $822.2K | ||
| 12 | U | United Therapeutics Corp | 2.48% | 53.6% | 1,532 | $761.6K | ||
| 13 | L | Eli Lilly & Co. | 2.33% | 55.9% | 643 | $717.4K | ||
| 14 | R | Regeneron Pharmaceuticals, Inc. | 2.19% | 58.1% | 862 | $673.6K | ||
| 15 | R | Repligen Corp | 1.92% | 60.1% | 3,569 | $589.5K | ||
| 16 | — | Argenx | 1.71% | 61.8% | 529 | $524.6K | ||
| 17 | — | Tempus Pe | 1.68% | 63.4% | 8,774 | $517.8K | ||
| 18 | N | Neurocrine Biosciences Inc | 1.67% | 65.1% | 3,276 | $511.8K | ||
| 19 | J | Jazz Pharmaceuticals Plc. | 1.52% | 66.6% | 1,895 | $465.8K | ||
| 20 | C | Charles River Laboratories International Inc | 1.51% | 68.1% | 1,667 | $463.9K | ||
| 21 | C | Caredx Inc | 1.40% | 69.5% | 8,571 | $430.8K | ||
| 22 | P | Praxis Precision Medicines, Inc. | 1.25% | 70.8% | 1,147 | $383.8K | ||
| 23 | — | Biontech Se Adr | 1.24% | 72.0% | 3,927 | $379.9K | ||
| 24 | G | Grail, Inc. | 1.18% | 73.2% | 4,774 | $363.9K | ||
| 25 | I | Insmed Inc | 1.15% | 74.4% | 2,728 | $353.0K | ||
| 26 | P | Ptc Therapeutics Inc | 1.15% | 75.5% | 5,366 | $354.5K | ||
| 27 | S | Stoke Therapeutics Inc | 1.15% | 76.7% | 12,159 | $353.0K | ||
| 28 | T | 10x Genomics Inc Com Usd 1 Cl A | 1.12% | 77.8% | 5,017 | $344.1K | ||
| 29 | I | Iqvia Holdings Inc | 1.10% | 78.9% | 1,290 | $337.7K | ||
| 30 | R | Revolution Medicines Inc | 1.02% | 79.9% | 1,544 | $314.6K | ||
| 31 | R | Royalty Pharma Plc Class A Ordinary Share | 1.01% | 80.9% | 5,276 | $309.2K | ||
| 32 | — | Kiniksa Pharmaceuticals, Ltd. | 1.00% | 81.9% | 4,016 | $306.3K | ||
| 33 | — | Samsung Biologics Co Ltd | 0.98% | 82.9% | 285 | $299.7K | ||
| 34 | V | Veracyte, Inc. | 0.97% | 83.9% | 7,289 | $297.9K | ||
| 35 | — | Crispr Therapeutics Ag Common Shares | 0.91% | 84.8% | 5,389 | $278.7K | ||
| 36 | T | Thermo Fisherscientific Inc. | 0.90% | 85.7% | 451 | $275.0K | ||
| 37 | H | Hinge Health Inc | 0.87% | 86.6% | 3,017 | $267.3K | ||
| 38 | — | Sartorius Ag Vorzug | 0.85% | 87.4% | 969 | $262.1K | ||
| 39 | A | Anaptysbio Inc | 0.81% | 88.2% | 4,596 | $247.6K | ||
| 40 | E | Eton Pharmaceuticals Inc. | 0.74% | 89.0% | 3,963 | $226.2K | ||
| 41 | A | Axsome Therapeutics Inc | 0.72% | 89.7% | 1,002 | $221.2K | ||
| 42 | C | Cadence Design Systems Inc. | 0.65% | 90.3% | 690 | $199.7K | ||
| 43 | A | Agilent Technologies Inc | 0.63% | 91.0% | 1,310 | $192.5K | ||
| 44 | B | Beam Therapeutics Inc. | 0.63% | 91.6% | 8,118 | $194.8K | ||
| 45 | T | First Tracks Biotherapeutics, Inc. | 0.60% | 92.2% | 5,045 | $183.8K | ||
| 46 | — | Roivant Sciences Ltd. Common Shares | 0.55% | 92.7% | 4,134 | $168.7K | ||
| 47 | — | Genmab A/s ADR | 0.54% | 93.3% | 5,120 | $166.2K | ||
| 48 | T | Tg Therapeutics Inc | 0.51% | 93.8% | 2,928 | $157.8K | ||
| 49 | — | AstraZeneca PLC | 0.51% | 94.3% | 975 | $156.2K | ||
| 50 | Q | Qiagen N.V. | 0.51% | 94.8% | 3,663 | $155.7K | ||
| More holdings · Pro | ||||||||
HELX ETF All Holdings
HELX holdings total 70 positions. The top 10 holdings account for 48.5% of the fund, led by Guardant Health, Inc at 9.3%, Natera Inc at 8.8%, Krystal Biotech Inc at 5.8%.
HELX portfolio concentration is moderate, with the top 10 representing 48.5% of total assets. The largest sector exposure is Health Care at 86.1%.
HELX sectors provide a detailed breakdown. HELX overlap shows how holdings compare to other funds in your portfolio.
HELX ETF Holdings
70 of 70 holdings
- 1
Guardant Health, Inc
GHHealth Care9.29% - 2
Natera Inc
NTRAHealth Care8.81% - 3
Krystal Biotech Inc
KRYSHealth Care5.75% - 4
Ligand Pharmaceuticals, Inc.
LGNDHealth Care4.41% - 5
Adaptive Biotechnologies Corp
ADPTHealth Care4.38% - 6
Twist Bioscience Corp.
TWSTHealth Care3.75% - 7
Bridgebio Pharma Inc_None_0
BBIOHealth Care3.32% - 8
Travere Therapeutics Inc
TVTXHealth Care3.26% - 9
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.78% - 10
Medpace Holdings Inc
MEDPHealth Care2.71% - 11
Corteva Inc Ctva
CTVAMaterials2.68% - 12
United Therapeutics Corp
UTHRHealth Care2.48% - 13
Eli Lilly & Co.
LLYHealth Care2.33% - 14
Regeneron Pharmaceuticals, Inc.
REGNHealth Care2.19% - 15
Repligen Corp
RGENHealth Care1.92% - 16
Argenx
ARGX:ASUnknown1.71% - 17
Tempus Pe
TEMInformation Technology1.68% - 18
Neurocrine Biosciences Inc
NBIXHealth Care1.67% - 19
Jazz Pharmaceuticals Plc.
JAZZHealth Care1.52% - 20
Charles River Laboratories International Inc
CRLHealth Care1.51% - 21
Caredx Inc
CDNAHealth Care1.40% - 22
Praxis Precision Medicines, Inc.
PRAXHealth Care1.25% - 23
Biontech Se Adr
BNTX:FFHealth Care1.24% - 24
Grail, Inc.
GRALHealth Care1.18% - 25
Insmed Inc
INSMHealth Care1.15% - 26
Ptc Therapeutics Inc
PTCTHealth Care1.15% - 27
Stoke Therapeutics Inc Com
STOKHealth Care1.15% - 28
10x Genomics Inc Com Usd 1 Cl A
TXGHealth Care1.12% - 29
Iqvia Holdings Inc
IQVHealth Care1.10% - 30
Revolution Medicines Inc
RVMDHealth Care1.02% - 31
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials1.01% - 32
Kiniksa Pharmaceuticals, Ltd.
KNSA:LNUnknown1.00% - 33
Samsung Biologics Co Ltd
207940:KRUnknown0.98% - 34
Veracyte, Inc.
VCYTHealth Care0.97% - 35
Crispr Therapeutics Ag Common Shares
CRSP:SMHealth Care0.91% - 36
Thermo Fisherscientific Inc.
TMOHealth Care0.90% - 37
Hinge Health Inc
HNGEFinancials0.87% - 38
Sartorius Ag Vorzug
SRT3:SGHealth Care0.85% - 39
Anaptysbio Inc
ANABHealth Care0.81% - 40
Eton Pharmaceuticals Inc.
ETONHealth Care0.74% - 41
Axsome Therapeutics Inc
AXSMHealth Care0.72% - 42
Cadence Design Systems Inc.
CDNSInformation Technology0.65% - 43
Agilent Technologies Inc
AInformation Technology0.63% - 44
Beam Therapeutics Inc. Com
BEAMHealth Care0.63% - 45
First Tracks Biotherapeutics, Inc.
TRAXUnknown0.60% - 46
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.55% - 47
Genmab A/s ADR
GMAB:COHealth Care0.54% - 48
Tg Therapeutics Inc Common Stock
TGTXHealth Care0.51% - 49
AstraZeneca PLC
AZN:LNUnknown0.51% - 50
Qiagen N.V.
QIA:ASUnknown0.51% - 51
Mineralys Therapeutics Inc
MLYSHealth Care0.50% - 52
Moderna therapeutics
MRNAHealth Care0.49% - 53
Glaukos Corp.
GKOSHealth Care0.47% - 54
Celcuity Inc Com
CELCHealth Care0.44% - 55
Veradermics Inc
MANEUnknown0.41% - 56
Cogent Biosciences Inc
COGTHealth Care0.40% - 57
Rhythm Pharmaceuticals Inc
RYTMHealth Care0.38% - 58
Arcutis Biotherapeutics Inc
ARQTHealth Care0.37% - 59
Bio-Rad Laboratories-A Common Stock
BIOHealth Care0.31% - 60
Tarsus Pharmaceuticals Inc
TARSHealth Care0.31% - 61
Beone Medicines Ltd
ONC:SMUnknown0.27% - 62
NEURogene
NGNEUnknown0.24% - 63
Liquidia Technologies Inc
LQDAHealth Care0.20% - 64
Genedx Holdings Corp
WGSHealth Care0.17% - 65
Samsung Episholdings Co L
0126Z0:KRUnknown0.14% - 66
Ultragenyx Pharmaceutical Inc
RAREHealth Care0.07% - 67
Cash
Other0.06% - 68
Omniab Inc 12.5 Earnout
OABIHealth Care0.00% - 69
Omniab Inc 15.00 Earnout
OABIHealth Care0.00% - 70
Net Current Assets
Other-0.01%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Guardant Health, Inc | GH | 9.290% | ||
| 2 | Natera Inc | NTRA | 8.810% | ||
| 3 | Krystal Biotech Inc | KRYS | 5.750% | ||
| 4 | Ligand Pharmaceuticals, Inc. | LGND | 4.410% | ||
| 5 | Adaptive Biotechnologies Corp | ADPT | 4.380% | ||
| 6 | Twist Bioscience Corp. | TWST | 3.750% | ||
| 7 | Bridgebio Pharma Inc_None_0 | BBIO | 3.320% | ||
| 8 | Travere Therapeutics Inc | TVTX | 3.260% | ||
| 9 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.780% | ||
| 10 | Medpace Holdings Inc | MEDP | 2.710% | ||
| 11 | Corteva Inc Ctva | CTVA | 2.680% | ||
| 12 | United Therapeutics Corp | UTHR | 2.480% | ||
| 13 | Eli Lilly & Co. | LLY | 2.330% | ||
| 14 | Regeneron Pharmaceuticals, Inc. | REGN | 2.190% | ||
| 15 | Repligen Corp | RGEN | 1.920% | ||
| 16 | Argenx | ARGX:AS | 1.710% | ||
| 17 | Tempus Pe | TEM | 1.680% | ||
| 18 | Neurocrine Biosciences Inc | NBIX | 1.670% | ||
| 19 | Jazz Pharmaceuticals Plc. | JAZZ | 1.520% | ||
| 20 | Charles River Laboratories International Inc | CRL | 1.510% | ||
| 21 | Caredx Inc | CDNA | 1.400% | ||
| 22 | Praxis Precision Medicines, Inc. | PRAX | 1.250% | ||
| 23 | Biontech Se Adr | BNTX:FF | 1.240% | ||
| 24 | Grail, Inc. | GRAL | 1.180% | ||
| 25 | Insmed Inc | INSM | 1.150% | ||
| 26 | Ptc Therapeutics Inc | PTCT | 1.150% | ||
| 27 | Stoke Therapeutics Inc Com | STOK | 1.150% | ||
| 28 | 10x Genomics Inc Com Usd 1 Cl A | TXG | 1.120% | ||
| 29 | Iqvia Holdings Inc | IQV | 1.100% | ||
| 30 | Revolution Medicines Inc | RVMD | 1.020% | ||
| 31 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 1.010% | ||
| 32 | Kiniksa Pharmaceuticals, Ltd. | KNSA:LN | 1.000% | ||
| 33 | Samsung Biologics Co Ltd | 207940:KR | 0.980% | ||
| 34 | Veracyte, Inc. | VCYT | 0.970% | ||
| 35 | Crispr Therapeutics Ag Common Shares | CRSP:SM | 0.910% | ||
| 36 | Thermo Fisherscientific Inc. | TMO | 0.900% | ||
| 37 | Hinge Health Inc | HNGE | 0.870% | ||
| 38 | Sartorius Ag Vorzug | SRT3:SG | 0.850% | ||
| 39 | Anaptysbio Inc | ANAB | 0.810% | ||
| 40 | Eton Pharmaceuticals Inc. | ETON | 0.740% | ||
| 41 | Axsome Therapeutics Inc | AXSM | 0.720% | ||
| 42 | Cadence Design Systems Inc. | CDNS | 0.650% | ||
| 43 | Agilent Technologies Inc | A | 0.630% | ||
| 44 | Beam Therapeutics Inc. Com | BEAM | 0.630% | ||
| 45 | First Tracks Biotherapeutics, Inc. | TRAX | 0.600% | ||
| 46 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.550% | ||
| 47 | Genmab A/s ADR | GMAB:CO | 0.540% | ||
| 48 | Tg Therapeutics Inc Common Stock | TGTX | 0.510% | ||
| 49 | AstraZeneca PLC | AZN:LN | 0.510% | ||
| 50 | Qiagen N.V. | QIA:AS | 0.510% | ||
| 51 | Mineralys Therapeutics Inc | MLYS | 0.500% | ||
| 52 | Moderna therapeutics | MRNA | 0.490% | ||
| 53 | Glaukos Corp. | GKOS | 0.470% | ||
| 54 | Celcuity Inc Com | CELC | 0.440% | ||
| 55 | Veradermics Inc | MANE | 0.410% | ||
| 56 | Cogent Biosciences Inc | COGT | 0.400% | ||
| 57 | Rhythm Pharmaceuticals Inc | RYTM | 0.380% | ||
| 58 | Arcutis Biotherapeutics Inc | ARQT | 0.370% | ||
| 59 | Bio-Rad Laboratories-A Common Stock | BIO | 0.310% | ||
| 60 | Tarsus Pharmaceuticals Inc | TARS | 0.310% | ||
| 61 | Beone Medicines Ltd | ONC:SM | 0.270% | ||
| 62 | NEURogene | NGNE | 0.240% | ||
| 63 | Liquidia Technologies Inc | LQDA | 0.200% | ||
| 64 | Genedx Holdings Corp | WGS | 0.170% | ||
| 65 | Samsung Episholdings Co L | 0126Z0:KR | 0.140% | ||
| 66 | Ultragenyx Pharmaceutical Inc | RARE | 0.070% | ||
| 67 | Cash | - | 0.060% | ||
| 68 | Omniab Inc 12.5 Earnout | OABI | 0.000% | ||
| 69 | Omniab Inc 15.00 Earnout | OABI | 0.000% | ||
| 70 | Net Current Assets | - | -0.010% |






































